COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2844: Articles 28431-28440  | Next

Rapid generation of neutralizing antibody responses in COVID-19 patients
Suthar, M. S., Zimmerman, M., Kauffman, R., Mantus, G., Linderman, S., Vanderheiden, A., Nyhoff, L., Davis, C., Adekunle, S., Affer, M., Sherman, M., Reynolds, S., Verkerke, H., Alter, D. N., Guarner, J., Bryksin, J., Horwath, M., Arthur, C., Saakadze, N., Smith, G. H., Edupuganti, S., Scherer, E. M., Hellmeister, K., Cheng, A., Morales, J. A., Neish, A. S., Stowell, S. R., Frank, F., Ortlund, E., Anderson, E., Menachery, V., Rouphael, N., Metha, A., Stephens, D. S., Ahmed, R., Roback, J., Wrammert, J.
10.1101/2020.05.03.20084442 — Posted: 2020-05-08
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implications
Caini, S., Bellerba, F., Corso, F., Diaz-Basabe, A., Natoli, G., Paget, J., Facciotti, F., Raimondi, S., Palli, D., Mazzarella, L., Pelicci, P. G., Vineis, P., Gandini, S.
10.1101/2020.05.03.20084160 — Posted: 2020-05-08
Shared Antigen-specific CD8+ T cell Responses Against the SARS-COV-2 Spike Protein in HLA A*02:01 COVID-19 Participants
Chour, W., Xu, A. M., Ng, A. H. C., Choi, J., Xie, J., Yuan, D., Lee, J. K., Delucia, D. C., Edmark, R., Jones, L., Schmitt, T. M., Chaffee, M. E., Duvvuri, V., Greenberg, P. D., Murray, K., Wallick, J., Algren, H. A., Berrington, W. R., O'Mahoney, D. S., Goldman, J. D., Heath, J. R.
10.1101/2020.05.04.20085779 — Posted: 2020-05-08 Discussion: Onsite
COVID-19 SCREENING AND MONITORING OF ASYMPTOMATIC HEALTH WORKERS WITH A RAPID SEROLOGICAL TEST
Paradiso, A. V., De Summa, s., Silvestris, N., Tommasi, S., Tufaro, A., De Palma, G., Larocca, A. M. V., D'Addabbo, V., Raffaele, D., Cafagna, V., Garrisi, V. M.
10.1101/2020.05.05.20086017 — Posted: 2020-05-08
Determinants of Severity in Cancer Patients with COVID-19 Illness
Robilotti, E. V., Babady, N. E., Mead, P. A., Rolling, T., Perez-Johnston, R., Bernardes, M., Bogler, Y., Caldararo, M., Figueroa-Ortiz, C., Glickman, M., Joanow, A., Kaltsas, A., Lee, Y. J., Lucca Bianchi, A., Mariano, A., Morjaria, S., Nawar, T., Papanicolaou, G. A., Predmore, J., Redelman-Sidi, G., Schmidt, E., Seo, S. K., Sepkowitz, K., Shah, M., Wolchok, J. D., Hohl, T. M., Taur, Y., Kamboj, M.
10.1101/2020.05.04.20086322 — Posted: 2020-05-08 Discussion: Onsite
Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
Freedberg, D. E., Conigliaro, J., Sobieszczyk, M. E., Markowitz, D. D., Gupta, A., O'Donnell, M. R., Li, J., Tuveson, D. A., Jin, Z., Turner, W. C., Landry, D. W., Wang, T. C., Tracey, K. J., Callahan, M. V., Abrams, J. A.
10.1101/2020.05.01.20086694 — Posted: 2020-05-08 Discussion: Onsite
Sensitivity of Nasopharyngeal, Nasal and Throat Swab for the Detection of SARS-CoV-2
Berenger, B. M., Fonseca, K., Schneider, A. R., Hu, J., Zelyas, N.
10.1101/2020.05.05.20084889 — Posted: 2020-05-08
IDentif.AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Blasiak, A., Lim, J. J., Seah, S. G. K., Kee, T., Remus, A., Chye, D. H., Wong, P. S., Hooi, L., Truong, A. T. L., Le, N., Chan, C. E. Z., Desai, R., Ding, X., Hanson, B. J., Chow, E. K.-H., Ho, D.
10.1101/2020.05.04.20088104 — Posted: 2020-05-08
Efficacy of remdesivir in COVID-19 patients with a simulated two-arm controlled study
Hsu, C.-Y., Lai, C.-C., Yen, A. M.-F., Chen, S. L.-S., Chen, H.-H.
10.1101/2020.05.02.20088559 — Posted: 2020-05-08
The Infection Rate of the Coronavirus Disease 2019 (COVID-19) in Wuhan, China
Qu, H., Cheng, Z., Duan, Z., Tian, L., Hakonarson, H.
10.1101/2020.05.02.20088724 — Posted: 2020-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).